BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 18572193)

  • 1. Sumoylation of specificity protein 1 augments its degradation by changing the localization and increasing the specificity protein 1 proteolytic process.
    Wang YT; Chuang JY; Shen MR; Yang WB; Chang WC; Hung JJ
    J Mol Biol; 2008 Jul; 380(5):869-85. PubMed ID: 18572193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sumoylation inhibits cleavage of Sp1 N-terminal negative regulatory domain and inhibits Sp1-dependent transcription.
    Spengler ML; Brattain MG
    J Biol Chem; 2006 Mar; 281(9):5567-74. PubMed ID: 16407261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of protein kinase G Increases the expression of p21CIP1, p27KIP1, and histidine triad protein 1 through Sp1.
    Cen B; Deguchi A; Weinstein IB
    Cancer Res; 2008 Jul; 68(13):5355-62. PubMed ID: 18593937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heat shock protein 90 is important for Sp1 stability during mitosis.
    Wang SA; Chuang JY; Yeh SH; Wang YT; Liu YW; Chang WC; Hung JJ
    J Mol Biol; 2009 Apr; 387(5):1106-19. PubMed ID: 19245816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sumoylation increases HIF-1alpha stability and its transcriptional activity.
    Bae SH; Jeong JW; Park JA; Kim SH; Bae MK; Choi SJ; Kim KW
    Biochem Biophys Res Commun; 2004 Nov; 324(1):394-400. PubMed ID: 15465032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of transcription factor activity by SUMO modification.
    Ouyang J; Valin A; Gill G
    Methods Mol Biol; 2009; 497():141-52. PubMed ID: 19107415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SUMO: a regulator of gene expression and genome integrity.
    Müller S; Ledl A; Schmidt D
    Oncogene; 2004 Mar; 23(11):1998-2008. PubMed ID: 15021887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of SUMO-1 on mitochondria subcellular localization of alpha-synuclein and its degradation via ubiquitin-proteasome system].
    Chen T; Liao XP; Wen GQ; Nong ZG; Ouyang F; Deng YD; Guo M; Wu HL; Zhou P
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2010 Jun; 27(3):267-71. PubMed ID: 20533263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sumoylation of Pdx1 is associated with its nuclear localization and insulin gene activation.
    Kishi A; Nakamura T; Nishio Y; Maegawa H; Kashiwagi A
    Am J Physiol Endocrinol Metab; 2003 Apr; 284(4):E830-40. PubMed ID: 12488243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SENP3 regulates the global protein turnover and the Sp1 level via antagonizing SUMO2/3-targeted ubiquitination and degradation.
    Wang M; Sang J; Ren Y; Liu K; Liu X; Zhang J; Wang H; Wang J; Orian A; Yang J; Yi J
    Protein Cell; 2016 Jan; 7(1):63-77. PubMed ID: 26511642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HDAC4 represses p21(WAF1/Cip1) expression in human cancer cells through a Sp1-dependent, p53-independent mechanism.
    Mottet D; Pirotte S; Lamour V; Hagedorn M; Javerzat S; Bikfalvi A; Bellahcène A; Verdin E; Castronovo V
    Oncogene; 2009 Jan; 28(2):243-56. PubMed ID: 18850004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptional activity of Sp1 is regulated by molecular interactions between the zinc finger DNA binding domain and the inhibitory domain with corepressors, and this interaction is modulated by MEK.
    Lee JA; Suh DC; Kang JE; Kim MH; Park H; Lee MN; Kim JM; Jeon BN; Roh HE; Yu MY; Choi KY; Kim KY; Hur MW
    J Biol Chem; 2005 Jul; 280(30):28061-71. PubMed ID: 15878880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of transcriptional corepressor activity of prospero-related homeobox protein (Prox1) by SUMO modification.
    Shan SF; Wang LF; Zhai JW; Qin Y; Ouyang HF; Kong YY; Liu J; Wang Y; Xie YH
    FEBS Lett; 2008 Nov; 582(27):3723-8. PubMed ID: 18948102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SUMO-1 overexpression increases RbAp46 protein stability and suppresses cell growth.
    Giri R; Yeh HH; Wu CH; Liu HS
    Anticancer Res; 2008; 28(6A):3749-56. PubMed ID: 19189660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of SUMO targets through in vitro expression cloning.
    Gocke CB; Yu H
    Methods Mol Biol; 2009; 497():51-61. PubMed ID: 19107410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down-regulation of hTERT expression plays an important role in 15-deoxy-Delta12,14-prostaglandin J2-induced apoptosis in cancer cells.
    Moriai M; Tsuji N; Kobayashi D; Kuribayashi K; Watanabe N
    Int J Oncol; 2009 May; 34(5):1363-72. PubMed ID: 19360348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Degradation of p21CDKN1A after DNA damage is independent of type of lesion, and is not required for DNA repair.
    Savio M; Coppa T; Cazzalini O; Perucca P; Necchi D; Nardo T; Stivala LA; Prosperi E
    DNA Repair (Amst); 2009 Jul; 8(7):778-85. PubMed ID: 19321391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SUMO-1 modification of centrosomal protein hNinein promotes hNinein nuclear localization.
    Cheng TS; Chang LK; Howng SL; Lu PJ; Lee CI; Hong YR
    Life Sci; 2006 Feb; 78(10):1114-20. PubMed ID: 16154161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repression of E1AF transcriptional activity by sumoylation and PIASy.
    Nishida T; Terashima M; Fukami K; Yamada Y
    Biochem Biophys Res Commun; 2007 Aug; 360(1):226-32. PubMed ID: 17585876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down-regulation of vascular endothelial growth factor receptor 2 is a major molecular determinant of proteasome inhibitor-mediated antiangiogenic action in endothelial cells.
    Meissner M; Reichenbach G; Stein M; Hrgovic I; Kaufmann R; Gille J
    Cancer Res; 2009 Mar; 69(5):1976-84. PubMed ID: 19223539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.